UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma

NPJ precision oncology, 2024-02, Vol.8 (1), p.27-27, Article 27

2024

Volltextzugriff (PDF)

International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2018-01, Vol.18 (1), p.2-11

2018

Volltextzugriff (PDF)

Technical Standards for Cancer Surgery: Commission on Cancer Standards 5.3–5.8

Annals of surgical oncology, 2022-10, Vol.29 (11), p.6549-6558

2022

Volltextzugriff (PDF)

Operative Standards for Cancer Care: One Step at a Time

Annals of surgical oncology, 2024-12, Vol.31 (13), p.8476-8478

2024

Volltextzugriff (PDF)

What Defines the Value of Minimally Invasive Surgery for Cancer Patients?

Annals of surgical oncology, 2024-04, Vol.31 (4), p.2204-2207

2024

Volltextzugriff (PDF)

ASO Author Reflections: Can We Measure ‘Value’?

Annals of surgical oncology, 2022-10, Vol.29 (11), p.6546-6547

2022

Volltextzugriff (PDF)

ASO Author Reflections: Technical Standards for Cancer Surgery: From “How I Do It” to “How We Do It”

Annals of surgical oncology, 2022-10, Vol.29 (11), p.6559-6560

2022

Volltextzugriff (PDF)

Serum CEA as a Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Non-Elevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment: A TAPS Consortium Study

Annals of surgical oncology, 2024-03, Vol.31 (3), p.1919-1932

2024

Volltextzugriff (PDF)

Supports and Barriers to Home-Based Physical Activity During Preoperative Treatment of Pancreatic Cancer: A Mixed-Methods Study

Journal of physical activity & health, 2019-12, Vol.16 (12), p.1113-1122

2019

Volltextzugriff (PDF)

ASO Visual Abstract: Serum CEA as Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment—A TAPS Consortium Study

Annals of surgical oncology, 2024-03, Vol.31 (3), p.1954-1955

2024

Volltextzugriff (PDF)

ASO Author Reflections: The Value of Serum CEA for Prognostication at Staging and Response Evaluation in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9

Annals of surgical oncology, 2024-03, Vol.31 (3), p.1842-1843

2024

Volltextzugriff (PDF)

Total Venous Control and Vein-to-the-Right Superior Mesenteric Artery Approach in Robotic Pancreatoduodenectomy

Annals of surgical oncology, 2024-12, Vol.31 (13), p.8721-8722

2024

Volltextzugriff (PDF)

What is “Value”? Results of a Survey of Cancer Patients and Providers

Annals of surgical oncology, 2022-10, Vol.29 (11), p.6537-6545

2022

Volltextzugriff (PDF)

Detection and Management of Perioperative Hyperglycemia at a Tertiary Cancer Center

Annals of surgical oncology, 2024-05, Vol.31 (5), p.3017-3023

2024

Volltextzugriff (PDF)

Response to Preoperative Therapy in Localized Pancreatic Cancer

Frontiers in oncology, 2020-04, Vol.10, p.516-516

2020

Volltextzugriff (PDF)

Correction: Standardization of Colon Resection for Cancer: An Overview of the American College of Surgeons Commission on Cancer Standard 5.6

Annals of surgical oncology, 2024-07, Vol.31 (7), p.4565-4565

2024

Volltextzugriff (PDF)

Transcriptomic Profile of Lymphovascular Invasion, a Known Risk Factor of Pancreatic Ductal Adenocarcinoma Metastasis

Cancers, 2020-07, Vol.12 (8), p.2033

2020

Volltextzugriff (PDF)

Surgical Considerations for Neoadjuvant Therapy for Pancreatic Adenocarcinoma

Cancers, 2023-08, Vol.15 (16), p.4174

2023

Volltextzugriff (PDF)

Clinical and Genetic Implications of DNA Mismatch Repair Deficiency in Patients With Pancreatic Ductal Adenocarcinoma

JAMA surgery, 2017-11, Vol.152 (11), p.1086

2017

Volltextzugriff (PDF)

Evaluation and Recalibration of Risk-Stratified Pancreatoduodenectomy Drain Fluid Amylase Removal Criteria

Journal of gastrointestinal surgery, 2023-12, Vol.27 (12), p.2806-2814

2023

Volltextzugriff (PDF)

ASO Visual Abstract: What is “Value”? Results of a Survey of Cancer Patients and Providers

Annals of surgical oncology, 2022-10, Vol.29 (11), p.6548-6548

2022

Volltextzugriff (PDF)

Physical activity and exercise during preoperative pancreatic cancer treatment

Supportive care in cancer, 2019-06, Vol.27 (6), p.2275-2284

2019

Volltextzugriff (PDF)

The Role of Home-Based Exercise in Maintaining Skeletal Muscle During Preoperative Pancreatic Cancer Treatment

Integrative cancer therapies, 2021, Vol.20, p.1534735420986615-1534735420986615

2021

Volltextzugriff (PDF)

Comparative Analyses of the Clinicopathologic Features of Short-Term and Long-Term Survivors of Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreatoduodenectomy

Cancers, 2023-06, Vol.15 (12), p.3231

2023

Volltextzugriff (PDF)

1 – 25 von 199

Suche als RSS-Feed

Aktive Filter

KollektionJSTOR

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(157)
Mit Volltextzugriff
(165)

Publikationsform

Sprache

Englisch
(196)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma

International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017

Technical Standards for Cancer Surgery: Commission on Cancer Standards 5.3–5.8

Operative Standards for Cancer Care: One Step at a Time

What Defines the Value of Minimally Invasive Surgery for Cancer Patients?

ASO Author Reflections: Can We Measure ‘Value’?

ASO Author Reflections: Technical Standards for Cancer Surgery: From “How I Do It” to “How We Do It”

Serum CEA as a Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Non-Elevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment: A TAPS Consortium Study

Supports and Barriers to Home-Based Physical Activity During Preoperative Treatment of Pancreatic Cancer: A Mixed-Methods Study

ASO Visual Abstract: Serum CEA as Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment—A TAPS Consortium Study

ASO Author Reflections: The Value of Serum CEA for Prognostication at Staging and Response Evaluation in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9

Total Venous Control and Vein-to-the-Right Superior Mesenteric Artery Approach in Robotic Pancreatoduodenectomy

What is “Value”? Results of a Survey of Cancer Patients and Providers

Detection and Management of Perioperative Hyperglycemia at a Tertiary Cancer Center

Response to Preoperative Therapy in Localized Pancreatic Cancer

Correction: Standardization of Colon Resection for Cancer: An Overview of the American College of Surgeons Commission on Cancer Standard 5.6

Transcriptomic Profile of Lymphovascular Invasion, a Known Risk Factor of Pancreatic Ductal Adenocarcinoma Metastasis

Surgical Considerations for Neoadjuvant Therapy for Pancreatic Adenocarcinoma

Clinical and Genetic Implications of DNA Mismatch Repair Deficiency in Patients With Pancreatic Ductal Adenocarcinoma

Evaluation and Recalibration of Risk-Stratified Pancreatoduodenectomy Drain Fluid Amylase Removal Criteria

ASO Visual Abstract: What is “Value”? Results of a Survey of Cancer Patients and Providers

Surgical Outcome After Distal Pancreatectomy With and Without Portomesenteric Venous Resection in Patients with Pancreatic Adenocarcinoma: A Transatlantic Evaluation of Patients in North America, Germany, Sweden, and The Netherlands (GAPASURG)

Physical activity and exercise during preoperative pancreatic cancer treatment

The Role of Home-Based Exercise in Maintaining Skeletal Muscle During Preoperative Pancreatic Cancer Treatment

Comparative Analyses of the Clinicopathologic Features of Short-Term and Long-Term Survivors of Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreatoduodenectomy

Aktive Filter

Suchergebnisse filtern